Prescription Required
Inclusive of all taxes
In Constipation Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free is a laxative that treats constipation by drawing water into the bowels thereby making stools softer and easier to pass. This medicine may take 6 to 12 hours to start working, therefore it is best to take it at bedtime. Take it as instructed even if it seems that it is not working as expected. Talk to your doctor if you are still constipated. Constipation is a common problem that can cause significant pain and discomfort. This medicine can relieve discomfort and improve your quality of life. To prevent constipation from happening it may help to eat more high-fiber foods including fruit and vegetables and drink plenty of water.
It is unsafe to consume alcohol with Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free.
Information regarding the use of Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free during pregnancy is not available. Please consult your doctor.
Information regarding the use of Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free during breastfeeding is not available. Please consult your doctor.
It is not known whether Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free may not be needed in these patients. Please consult your doctor.
Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Eva Q Plus Oral Emulsion Strawberry Mint Sugar Free may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Flaring Formulations Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Amwin Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Stenkem Molecules Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Volus Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: S.Bee Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Saffron Therapeutics Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: SAF Fermion Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Healthlon Pharmaceuticals || ₹14.5/tablet (25% cheaper)